Related Experiment Video
Updated: Oct 22, 2025
08:45
Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
2.6K
N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions
Bingying Du1, Yanbo Zhang2, Meng Liang1
1Department of Neurology, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, PR China.
Aging
|August 30, 2021
Summary
N6 adenosine methylation (m6A) is crucial in cell regulation. This study identifies m6A regulators as potential biomarkers for predicting cognitive decline and Alzheimer's disease progression.
Area of Science:
- Epigenetics and Molecular Biology
- Neuroscience
- Biomarker Discovery
Background:
- N6 adenosine methylation (m6A) is the most prevalent internal RNA modification in eukaryotes.
- m6A dysregulation is linked to cell proliferation and death, but its role in neurodegeneration and cognitive dysfunction remains unclear.
Purpose of the Study:
- To investigate molecular alterations of m6A regulators in neurodegenerative diseases.
- To assess the clinical relevance of m6A regulators in cognitive dysfunction, including Alzheimer's Disease (AD), vascular dementia, and mild cognitive impairment (MCI).
Main Methods:
- Systematic investigation of m6A regulators using published datasets.
- Analysis of gene expression data from AD, vascular dementia, and MCI cohorts.
- Exploration of correlations between Apolipoprotein E4 and m6A methylations.
Main Results:
- m6A regulator expression varies across tissues and correlates with neurodegenerative pathways.
- SNRPG and SNRPD2 identified as co-expressive m6A regulators.
- Potential biomarkers for predicting MCI to AD transformation and links to Apolipoprotein E4 established.
Conclusions:
- m6A methylations show promise as biomarkers for cognitive dysfunction.
- m6A regulators represent potential therapeutic targets for neurodegenerative diseases and cognitive impairment.
Related Concept Videos
02:23RNA Editing
9.3K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.3K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
250
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
250
01:28Biosynthesis of Nucleic Acids
345
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
345
01:26Alzheimer's Disease: Overview
781
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
781
01:53RNA Stability
34.2K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
34.2K
02:31Nuclear Export of mRNA
8.0K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.0K